Emergency communication test Sept. 19
Washington University in St. Louis plans to test its emergency communication system at 9:55 a.m. Sept. 19.
Stanley Paul Hmiel, MD, PhD, pediatric nephrologist, 64
Stanley Paul Hmiel, MD, PhD, a pediatric nephrologist at the School of Medicine, died surrounded by family Aug. 28 at a hospice in Creve Coeur, Mo., after a three-year struggle with colon cancer. He was 64.
Honorary degree nominations sought
Members of the WashU community may nominate honorary degree candidates for the May 2025 Commencement. The deadline is Sept. 25.
Welcome home, Class of 2027!
The Class of 2027 celebrated Convocation Aug. 26 in Brookings Quadrangle, heard from WashU leaders and then enjoyed Party at the Park, to kick off the academic year.
Mennerick named director of Division of Biology & Biomedical Sciences
Neuroscientist Steven Mennerick, the John P. Feighner Professor of Neuropsychopharmacology at the School of Medicine, has been named director and associate dean of the Roy and Diana Vagelos Division of Biology & Biomedical Sciences.
Carlos A. Perez, MD, professor emeritus of radiation oncology, 88
Carlos A. Perez, MD, an internationally renowned cancer researcher and professor emeritus of radiation oncology at the School of Medicine, died Aug. 21 in Springfield, Mo.
How do developing brains assemble and organize themselves?
Researchers led by the School of Medicine’s Linda J. Richards published a study describing some of the earliest events in brain development. The findings lay the groundwork for understanding the roots of brain conditions such as epilepsy, autism and intellectual disability.
Parking shares fall update
Parking and Transportation Services at Washington University in St. Louis shares back-to-campus updates on parking passes, U-Pass registration and upcoming high-volume events
Gomez honored for diversity work by Business Journal
Trish Gomez, associate director in the Office of Institutional Equity, is being recognized as a “champion for diversity and inclusion” by the St. Louis Business Journal.
What to know about the new Alzheimer’s drug Leqembi
The Food and Drug Administration has granted full approval to Leqembi for patients in the early stages of Alzheimer’s disease. The School of Medicine’s Barbara Joy Snider, MD, PhD, answers questions about the drug.
View More Stories